Zimbabwe has turned down a substantial American health deal worth $367m (£272m) over five years over the United States' request for confidential data.
The decision was revealed after a internal memorandum dated December was disclosed, which showed Head of State Emmerson Mnangagwa believed the agreement was "skewed".
A government spokesperson has since clarified that the United States was demanding access to biological samples for research and commercial gain while was unwilling to guarantee the resulting advantages from future medical innovations.
"We are forced to start the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had furnished more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has urged continued talks to reach a agreement agreeable to all parties so the nation's critical HIV programme can be sustained.
Wider Implications
Zimbabwe's decision follows a similar case in neighbouring Kenya, where a high court halted a related health funding agreement after legal challenges were filed about the safety of citizens' medical information.
After resuming office recently, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).
USAID had administered assistance for the US government, but Trump stated its expenditure was "wasteful" and his administration was seeking government-to-government agreements to enhance openness and responsibility.
Based on reports, Sixteen African countries have to date agreed to these new health pacts, representing over $18.3bn in new funding.
Specifics of the Rejected Deal
This assistance for Zimbabwe would have supported "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We believe this cooperation could have provided significant benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy through American-funded initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"The proposal required Zimbabwe to share its biological resources and data indefinitely, without any corresponding assurance of access to any scientific breakthroughs – such as new medicines or tests – that could be developed from that provided information," he stated.
"Put simply, our country would provide the raw materials for scientific discovery with no certainty that the final treatments would be accessible to our people should a new pandemic arise."
National Interest and Global Health
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting structures already set up through the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with potential pandemics.
"This system is intended to ensure that when a nation contributes its information, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised solely by those with the capability to create them."
Zimbabwe's reservations regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We are open to continued discussions with our American counterparts on how subsequent collaboration might be structured in a way that respects the sovereignty and dignity of both nations."
Health Experts Response
A leading public health body said it understood the government's concerns, but recommended that talks must proceed given that much of the nation's Aids initiatives relied on foreign aid.
"In cases where specific concerns arise, including those relating to data governance or agreement terms, these can frequently be resolved via detailed discussion and mutually agreed protections," the group commented.
The situation highlights the continuing debate between receiving vital international aid and protecting local interests in an increasingly interconnected world.